- Conditions: Dementia; Alzheimer's Disease
Intervention: Other: PC-DATA tool
Sponsors: Queen's University; Queen's University; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified March 2012 - Condition: Healthy
Intervention: Dietary Supplement: omega-3 fatty acids
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke
Recruiting - verified February 2012 - Conditions: Moderate to Severe Alzheimer; Alzheimer Disease
Interventions: Drug: RPh201, botanical drug product; Drug: Placebo; Drug: RPh201, botanical extract product; Drug: Placebo
Sponsors: Regenera Pharma Ltd; Regenera Pharma Ltd; Kendle Toronto, Inc, a wholly-owned subsidiary of INC Research LLC
Recruiting - verified January 2012 - Condition: Alzheimer's Disease
Interventions: Drug: BMS-241027; Drug: BMS-241027; Drug: BMS-241027; Drug: Placebo matching BMS-241027
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Drug: rilapladib; Drug: placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Dementia
Intervention:
Sponsors: Laval University; Laval University
Not yet recruiting - verified September 2011 - Condition: Frontotemporal Dementia
Interventions: Drug: oxytocin; Drug: Saline Nasal Mist
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute; The Consortium of Canadian Centres for Clinical Cognitive Research (C5R)
Recruiting - verified June 2011 - Condition: Alzheimer's Disease
Interventions: Drug: MABT5102A; Drug: MABT5102A; Drug: placebo; Drug: placebo
Sponsors: Genentech; Genentech
Recruiting - verified April 2012 - Condition: Dementia Alzheimer's Type
Interventions: Drug: SAR110894D; Drug: placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Conditions: Mild Cognitive Impairment (MCI); Alzheimer's Disease
Intervention:
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); Alzheimer's Disease Cooperative Study (ADCS); Northern California Institute for Research and Education (NCIRE); National Institute on Aging (NIA)
Recruiting - verified May 2012 - Conditions: Oxidative Stress; Inflammation; Aging; Dementia; Pain
Intervention: Dietary Supplement: secoisolariciresinol diglucoside
Sponsors: University of Saskatchewan; University of Saskatchewan; Saskatchewan Health Research Foundation
Recruiting - verified October 2011 - Condition: Alzheimer Disease
Interventions: Drug: gantenerumab; Drug: gantenerumab; Drug: placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Intervention: Drug: Solanezumab
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Mild Cognitive Impairment; Alzheimer's Disease
Intervention:
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); Alzheimer's Disease Cooperative Study (ADCS); Northern California Institute for Research and Education (NCIRE); National Institute on Aging (NIA)
Recruiting - verified February 2012 - Conditions: Alzheimer's Disease; Agitation
Interventions: Drug: citalopram; Drug: placebo
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Aging (NIA); National Institute of Mental Health (NIMH)
Recruiting - verified May 2012 - Condition: Thoracic Aortic Vascular Disease
Intervention: Procedure: Repair of descending thoracic aneurysm and morphine
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Recruiting - verified April 2009 - Condition: Alzheimer Disease
Interventions: Drug: bapineuzumab; Drug: bapineuzumab; Drug: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012
 |
Join Clinical Trials for Alzheimer Disease in Canada |
